Fed Bioavailability Study of Lovastatin Tablets and Mevacor Tablets
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2010-01-20
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT00684723
- Locations
- 🇨🇦
Algorithme Pharma, Montreal, Quebec, Canada
Fasting Bioavailability Study of Lovastatin Tablets and Mevacor Tablets
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2010-01-20
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT00685685
- Locations
- 🇨🇦
Algorithme Pharma, Montreal, Canada
Fasted Bioavailability Study of Cilostazol Tablets, 100 mg
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2009-12-22
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00684762
Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-15
- Last Posted Date
- 2011-05-03
- Lead Sponsor
- Mutual Pharmaceutical Company, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT00658541
© Copyright 2024. All Rights Reserved by MedPath